Recent guidelines for non-alcoholic fatty liver disease (NAFLD)/ fatty liver disease (FLD): are they already outdated and in need of supplementation
Alrededor del 30% de las personas en el Oeste y el Noreste padecen obesidad
GLP-1 receptor agonists are medications that mimic the action of the natural GLP-1 hormone, which helps regulate blood sugar levels, suppress appetite, and promote weight loss
Vyvanse (lisdexamfetamine) is classified by the DEA as a schedule II controlled substance, which is applied to drugs considered to have a high likelihood of being abused, so additional prescribing safeguards are put in place
Benefits of Weight Loss Programs Weight loss programs can offer several advantages beyond the number on the scale: Clear structure that reduces decision fatigue about what to eat and how to move
This approach allows the clinical team to adjust the protocol before significant volume loss occurs, rather than trying to reverse it afterward